Hematopoietic Stem Cell Transplantation
Conditions
Interventions
Randomized, double-blind, controlled, longitudinal, prospective, interventional clinical trial. Whey protein group: 15 patients receive whey protein supplementation (whey protein) in the amount of 1g
G07.203.300.456
Sponsors
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto
Fundação Pio XII
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age greater than or equal to 18 years; both genders; diagnosis of hematological neoplasms; with indication of the first allogeneic stem cell transplantation
Exclusion criteria
Exclusion criteria: Acute kidney injury; chronic kidney disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome: with the use of whey protein supplementation plus leucine will promote muscle mass recovery during allogeneic hematopoietic stem cell transplantation, measured from anthropometric assessment, functionality assessment, body composition assessment and biochemical tests. Data are collected in the preconditioning period, on the day of hematopoietic stem cell infusion, 21 days after infusion, and 100 days after infusion. | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome: the use of whey protein supplementation plus leucine will promote positive nitrogen balance during allogeneic hematopoietic stem cell transplantation, measured from the assessment of nitrogen balance. Data are collected in the preconditioning period, on the day of hematopoietic stem cell infusion, 21 days after infusion, and 100 days after infusion. | — |
Countries
Brazil
Contacts
Public ContactIsabela Schiavoni
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto
Outcome results
None listed